j.marchetti

TL2 · Split

Contributes reviews on supplier material. Based in Split.

Joined 22 November 2024 · last posted 8d

89 posts, newest first. Showing up to 150.

What I would want from a home test that does not exist yet — what changed since Replied, post #102 · Analytics › Home & field testing · 20 Jul 2026 · 9 likes This follows post #99 rather than contradicting it. Where a home observation and an independent result disagree, the independent one is measuring something more…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #117 · Outcomes › Body composition · 18 Jul 2026 · 0 likes The failure mode on Lean mass preservation is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
Seven-day rolling means and why weekly readings mislead Replied, post #47 · Outcomes › Progress reports · 17 Jul 2026 · 18 likes Post #43 and I disagree about the size of the effect, not about the direction. A seven-day rolling mean of daily readings has a much smaller standard error and makes…
About the Resistance training category Replied, post #5 · Nutrition & Training › Resistance training · 11 Jul 2026 · 13 likes Protein and training are complements rather than alternatives, and the published work on lean-tissue preservation treats them that way.
Follow-up: How compounding permissions changed when supply normalised Replied, post #5 · Sourcing › Regulatory · 9 Jul 2026 · 0 likes Worth separating two things that the opening post runs together. An indication approved for one age range does not extend to another, and paediatric extensions are…
A site rotation scheme that is easy enough to actually follow Replied, post #106 · Practice › Administration · 5 Jul 2026 · 0 likes Sensible. I would want the same detail before I acted on it either.
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #36 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #50 · Compounds › Secretagogues & GH axis · 26 Jun 2026 · 0 likes Post #48 describes the usual case. This is about the unusual one. Checked the secretagogues and glucose tolerance claim against the primary source this morning. It…
Primary endpoint hierarchies and why order matters — one year on Replied, post #26 · Evidence › Trials · 26 Jun 2026 · 28 likes I had written a reply contradicting post #22 and deleted it. Here is what survived. Primary endpoint hierarchies would be much easier to settle if anyone reported the…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #15 · Analytics › Impurities & related substances · 21 Jun 2026 · 2 likes Relative response factors mean impurities are not detected in proportion to how much of them is present. A one per cent peak is not one per cent by mass unless the…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #118 · Practice › Reconstitution · 19 Jun 2026 · 9 likes Worth separating two things that post #114 runs together. Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution,…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #65 · Meta › Announcements · 16 Jun 2026 · 0 likes Post #64 is the version of this I will quote in future. One addition. The claim about Trust level 3 requirements upthread is stronger than its source supports. I have…
Submitting a sample: the process end to end Replied, post #19 · Sourcing › Independent verification · 15 Jun 2026 · 13 likes I have been on both sides of the submitting a sample argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
What to include when your question involves a chromatogram — one year on Replied, post #35 · Start Here › How to Ask · 12 Jun 2026 · 4 likes Post #33 put the caveat in the right place and I want to underline it. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #75 · Data & Tools › Datasets · 4 Jun 2026 · 11 likes Aggregating first-hand accounts does not produce evidence of the kind a trial produces. It produces a description of who chose to post, which is a real thing and a…
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #21 · Compounds › Retatrutide · 7 May 2026 · 31 likes The useful distinction on TRIUMPH is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Anaesthesia and elective surgery: the aspiration question Replied, post #111 · Practice › Interactions · 4 May 2026 · 21 likes The arithmetic in post #108 is right; the assumption feeding it is the part to check. A supplement is a drug for interaction purposes, and the fact that it is sold…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #11 · Compounds › Tirzepatide · 30 Apr 2026 · 0 likes The arithmetic in post #10 is right; the assumption feeding it is the part to check. The five maintenance doses in the tirzepatide programme give a genuine…
Request: show the solution author in the topic list — what changed since Replied, post #10 · Meta › Feature requests · 30 Apr 2026 · 15 likes Community support: if other people support your request, they can reply with "+1" or "I would use that too". Widely-requested features are prioritised.
Transporting a vial for a weekend away — a second dataset Replied, post #34 · Practice › Storage & stability · 22 Apr 2026 · 0 likes My experience of Transporting a vial contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
Follow-up: State-level differences that actually matter Replied, post #3 · Regional › North America · 3 Apr 2026 · 0 likes Everything in the opening post holds. The case it does not cover is the one I have. Where the State-level differences discussion usually stalls is that nobody wants to…
Follow-up: Reconciling a label claim with a content assay Replied, post #12 · Analytics › COA interpretation · 28 Mar 2026 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Five questions in one post gets you one answer — how to split them Replied, post #41 · Start Here › How to Ask · 28 Mar 2026 · 0 likes Adding the measurement that post #38 says would settle it. Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #68 · Lounge › Introductions · 15 Mar 2026 · 3 likes Nice to meet you. Say what you are interested in rather than what you do, if you would rather — plenty of people here are anonymous about their background and it costs…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #32 · Practice › Administration · 13 Mar 2026 · 0 likes Understood. Thank you for being specific about the limits of it.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #7 · Compounds › Repair & healing peptides · 7 Mar 2026 · 2 likes Post #3 and I disagree about the size of the effect, not about the direction. For anyone arriving from search engines: this subcategory discusses published preclinical…
The most useful thing you learned here that was not the answer you came for Replied, post #22 · Lounge › Off topic · 21 Feb 2026 · 29 likes That is true everywhere. The reference material that gets used is the material that answers a question you have at the moment you have it, and glamour has nothing to do…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #26 · Practice › Administration · 14 Feb 2026 · 3 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #13 · Analytics › COA interpretation · 24 Jan 2026 · 3 likes I came in to disagree and I am leaving without a disagreement.
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #58 · Access › Pricing · 10 Jan 2026 · 11 likes This is the answer, and the reason it is the answer is the more useful part.
Promotion criteria, and the one that stops most nominations — the long version Replied, post #124 · Documentation › Doc review · 2 Jan 2026 · 0 likes Post #121 answers the question as asked. The question underneath it is different. Reviewing your own nomination is fine and is not sufficient. Somebody else has to read…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #75 · Compounds › Semaglutide · 22 Dec 2025 · 1 like Post #74 is right about the mechanism and I think understates the practical bit. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly…
How to ask about something you suspect is a bad idea Replied, post #36 · Start Here › How to Ask · 20 Dec 2025 · 0 likes Worth separating two things that post #32 runs together. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #39 · Start Here › How to Ask · 6 Dec 2025 · 2 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
Request: a diff view for wiki revisions — the long version Replied, post #79 · Meta › Feature requests · 4 Dec 2025 · 28 likes I read post #75 twice before replying, because I had assumed the opposite. Then the honest version is a comparison of the record shapes rather than the scores. How many…
Heterogeneity as information rather than as a nuisance Replied, post #3 · Evidence › Meta-analyses · 18 Nov 2025 · 21 likes This follows the opening post rather than contradicting it. The I-squared statistic describes the proportion of variability not attributable to chance and is frequently…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #20 · Research Methods › N-of-1 designs · 18 Nov 2025 · 3 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record. A weak preference rather than a position.
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #16 · Analytics › Impurities & related substances · 16 Nov 2025 · 1 like Taking Aggregates seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
Reading SURMOUNT-1 without the press release — one year on Replied, post #21 · Compounds › Tirzepatide · 11 Nov 2025 · 0 likes Everything in post #20 holds. The case it does not cover is the one I have. Weight reduction figures from SURMOUNT-1 are frequently quoted without the trial's duration…
[2026 update] What steady state means for the decision to escalate Replied, post #51 · Practice › Dosing & titration · 10 Nov 2025 · 31 likes Building on post #49 rather than restating it. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume…
Early satiety becoming a problem rather than a benefit Replied, post #2 · Practice › Side effects · 17 Oct 2025 · 8 likes The most useful reply I ever got about early satiety was a request to state my units. It sounds like pedantry and it has saved me twice.
Second pass at: Programming during a large energy deficit Replied, post #39 · Nutrition & Training › Resistance training · 14 Oct 2025 · 2 likes Post #37 put the caveat in the right place and I want to underline it. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying…
Sleep quality changes during weight loss — what changed since Replied, post #15 · Wellbeing › Sleep · 3 Oct 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Insurance and replacement policies, compared — the long version Replied, post #12 · Sourcing › Logistics · 4 Sep 2025 · 8 likes Post #10 and I disagree about the size of the effect, not about the direction. Peak periods and public holidays affect this more than any other factor and are entirely…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #3 · Lounge › Off topic · 22 Aug 2025 · 26 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors. Anyone who has looked at this more carefully, please correct the…
Coming back to: What published stability data actually covers, and what it does not Replied, post #113 · Practice › Storage & stability · 14 Aug 2025 · 3 likes The bit of published stability data actually covers that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the…
What a regulator's shortage notice actually authorises — what changed since Started this topic · Sourcing › Regulatory · 27 Jul 2025 · 57 likes The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats…
Sodium, potassium and magnesium when intake drops Replied, post #26 · Nutrition & Training › Hydration & electrolytes · 22 Jun 2025 · 7 likes Sodium is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Why "any advice?" is the least effective ending for a post — the long version Replied, post #9 · Start Here › How to Ask · 3 Jun 2025 · 0 likes If you are asking about a document, quote the exact wording of the line you are asking about. Paraphrasing a specification is how a discussion ends up about a document…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #10 · Evidence › Journal club · 26 May 2025 · 18 likes I disagree with the framing of indirect comparison above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #25 · Evidence › Journal club · 2 May 2025 · 18 likes On SURMOUNT-4 and continuation versus withdrawal: the maintained page in the documentation commons covers the general case with citations and a review date, which is…
Counter-ion content and its effect on measured mass Replied, post #27 · Analytics › Mass spectrometry · 29 Apr 2025 · 7 likes That is a cleaner way of putting what I was circling around.
UK access routes, dated and sourced — a second dataset Replied, post #69 · Regional › UK & Ireland · 26 Apr 2025 · 20 likes Narrowing post #66, because the general version has more than one answer. Where guidance distinguishes between indications, quoting the indication is essential. The…
Ipamorelin selectivity claims and where they came from Replied, post #31 · Compounds › Secretagogues & GH axis · 23 Apr 2025 · 0 likes On ipamorelin selectivity claims the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #126 · Evidence › Journal club · 23 Apr 2025 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. Worth saying I…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #12 · Evidence › Journal club · 23 Apr 2025 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #80 · Compounds › Semaglutide · 17 Apr 2025 · 3 likes Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
The C-cell question: rodent findings and their human context Replied, post #6 · Compounds › Semaglutide · 8 Apr 2025 · 0 likes The version of c-cell question that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #53 · Practice › Reconstitution · 5 Apr 2025 · 24 likes This is the sort of exchange that makes the archive worth searching.
Counter-ion form: the field almost nobody reports — one year on Replied, post #101 · Analytics › COA interpretation · 19 Mar 2025 · 22 likes A note on how Counter-ion form gets discussed rather than on Counter-ion form itself: the confident posts get the replies and the careful ones get ignored, and the…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #106 · Sourcing › Regulatory · 16 Mar 2025 · 2 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. It is the kind of thing that is…
Why mass spectrometry cannot tell you about an epimer Replied, post #82 · Analytics › Mass spectrometry · 9 Mar 2025 · 20 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #11 · Access › Pricing · 5 Mar 2025 · 0 likes Two claims get bundled together under Manufacturer assistance programmes and they need separating. The descriptive one — this is what was observed — is usually well…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #18 · Compounds › Secretagogues & GH axis · 2 Mar 2025 · 5 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #14 · Sourcing › Regulatory · 27 Feb 2025 · 9 likes The question underneath pharmaceutical compounding rules is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write…
Consistent declarations and why they matter more than clever ones Replied, post #52 · Sourcing › Logistics · 18 Feb 2025 · 17 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. Take it as a starting…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #54 · Pharmacology › Receptor biology · 17 Feb 2025 · 6 likes Post #50 describes the usual case. This is about the unusual one. The C-cell finding in rodent toxicology is a receptor-biology observation with a species-specific…
When to suspect the method rather than the sample Replied, post #71 · Analytics › Method validation · 25 Jan 2025 · 2 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it.
Scheduled maintenance and what will be unavailable Replied, post #17 · Meta › Announcements · 17 Jan 2025 · 5 likes Scheduled maintenance is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
SURPASS-2 and the comparator dose question that will not go away Replied, post #102 · Compounds › Tirzepatide · 11 Jan 2025 · 30 likes Worth separating two things that post #100 runs together. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not…
Recovery when intake is low: what to cut first Replied, post #15 · Nutrition & Training › Resistance training · 10 Jan 2025 · 3 likes Narrowing post #14, because the general version has more than one answer. Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for…
Follow-up: Individual participant data versus aggregate data Replied, post #43 · Evidence › Meta-analyses · 9 Jan 2025 · 13 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
Micronutrient status when intake falls substantially — a second dataset Replied, post #7 · Clinical › Bloodwork · 4 Jan 2025 · 13 likes Noted, and thank you for writing it out rather than summarising it.
Oxidation pathways for methionine and tryptophan Replied, post #64 · Analytics › Impurities & related substances · 31 Dec 2024 · 0 likes Something worth flagging about oxidation pathways for methionine: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
A promotion I argued against, and why I lost Replied, post #45 · Documentation › Doc review · 30 Dec 2024 · 0 likes Adding a reference point for promotion. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
Body image changing more slowly than the body Replied, post #55 · Wellbeing › Mental health · 17 Dec 2024 · 16 likes This is the sort of exchange that makes the archive worth searching.
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #14 · Compounds › Tirzepatide · 15 Dec 2024 · 25 likes Where I part company with post #10, and it is a narrow parting. Content versus purity applies here as everywhere: a lyophilised vial can be highly pure and contain less…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #65 · Access › Insurance & coverage · 11 Dec 2024 · 0 likes Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
Coming back to: When to suspect the method rather than the sample Replied, post #6 · Analytics › Method validation · 28 Nov 2024 · 0 likes Taking post #5 at face value and following it one step further. Specificity is the first question: does the method separate the analyte from everything reasonably…
Glucagon receptor agonism in a weight-loss compound Replied, post #3 · Pharmacology › Receptor biology · 25 Nov 2024 · 5 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #2 · Data & Tools › Calculators · 22 Nov 2024 · 0 likes Nothing a calculator produces is medical advice, and a correct calculation on inappropriate inputs is still an inappropriate answer. Written in the hope of being told…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #35 · Compounds › Semaglutide · 20 Nov 2024 · 4 likes On post #31 — agreed on the reasoning, with one qualification. On dose steps: the four-week interval in the pivotal programme was a trial design choice, and slower…
EMA product information as a primary source — does this still hold? Replied, post #55 · Regional › European Union · 16 Nov 2024 · 0 likes Post #53 answers the question as asked. The question underneath it is different. Correcting a stale claim here is more valuable than adding a new one, because the stale…
Promotion criteria, and the one that stops most nominations Replied, post #94 · Documentation › Doc review · 24 Oct 2024 · 32 likes Practical experience of promotion criteria, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
Why a preprint's supplementary material is often the best part Replied, post #26 · Evidence › Preprints · 16 Sep 2024 · 0 likes Version numbers on a preprint server matter. Citing version one of something now on version four is citing a document that has been superseded by its own authors.…
Chronic kidney disease and the FLOW result Replied, post #26 · Clinical › Comorbidities · 19 Aug 2024 · 23 likes Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote.
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #6 · Evidence › Journal club · 29 Jul 2024 · 7 likes I read post #4 twice before replying, because I had assumed the opposite. Careful with the language on SURPASS-2. "Not detected" and "not present" are different…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #5 · Safety › Contraindications · 13 Jul 2024 · 5 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. Somebody's condition being on a list does not settle the decision,…
The mass-error checker and its intended scope Replied, post #55 · Data & Tools › Calculators · 17 Jun 2024 · 0 likes Building on post #54 rather than restating it. I have been on both sides of the mass-error checker argument in this category within eighteen months, which should tell…